Syndrome with difference of sex development of gynecological interest Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

Regulatory Watchboard

2 events

Feb 2026VYKOURA: FDA approved

FDAcompleted

Dec 1991

Leucovorin calcium: FDA approved

For use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Syndrome with difference of sex development of gynecological interest.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Leucovorin calcium

(Leucovorin)Orphan drug

Immunex Corporation

Approved Dec 1991FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Syndrome with difference of sex development of gynecological interest.
Search all trials →

Search clinical trials for Syndrome with difference of sex development of gynecological interest →

Recent News & Research

No recent news articles indexed yet for Syndrome with difference of sex development of gynecological interest.
Search PubMed for Syndrome with difference of sex development of gynecological interest →

Browse all Syndrome with difference of sex development of gynecological interest news →

Specialist Network

No specialists currently listed for Syndrome with difference of sex development of gynecological interest.

View all Syndrome with difference of sex development of gynecological interest specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰